Medical device company restor3d has raised US$23 million as it looks to expand delivery of its 3D-printed personalised surgical solutions across multiple musculoskeletal specialties. The financing will also go towards developing machine learning software tools for assisting engineers with patient specific implant design.
Ken Gall, co-founder of restor3d and a professor at Duke University (Durham, USA), says the company will be deploying the capital on new product introductions and enhanced 3D-printed personalised surgical solutions for upper/lower extremity, spine, and trauma.
In addition, the financing will be used for the ongoing development of machine learning enabled software for surgical planning and implant design, as well as research, preclinical, and clinical studies, and the expansion of its commercial team.
